Table 1.
Category | Biotargets | Magnetic Substrates | LOD | Ref. |
---|---|---|---|---|
Amino acid and protein | Uric acid | Ag/ZnO/Fe3O4 | 365 nmol/L | [97] |
Glycated hemoglobin | Ag-coated magnetic polymethacrylate microspheres | 50 ng/L | [98] | |
Human carboxylesterase 1 | Fe3O4@SiO2@Ag | 0.1 ng/L | [99] | |
DNA and RNA sequences | ssDNA associated with BRAF V600E mutation | MNP@SiO2@Au | 5.15 × 10−11 mol/L | [100] |
C. krusei and C. albicans target DNA | Ag@MNP | 20 fmol/L | [101] | |
Tumor biomarker | CEA | Raspberry-like Fe3O4@Au | 1.43 pg/mL | [102] |
Bacteria and secretions | Deoxynivalenol | Complementary DNA modified-Fe3O4@Au | 0.032 pg /mL | [103] |
Zearalenone | Fe3O4@Au | 0.001 ng/mL | [104] | |
E. coli, L. mono and S. typhi | Aptamer modified-Fe3O4@Au | 10 cells/mL (E. coli), 10 cells/mL (L. mono) and 25 cells/mL (S. typhi) | [105] | |
E. coli, S. aureus and Salmonella | Magnetic Au@Ag | 20 cells/mL (E. coli), 13 cells/mL (S. aureus) and 19 cells/mL (Salmonella) |
[106] | |
Hormones and antibiotics | Luteinizing hormone | Antibody modified-Fe3O4@AuNP | 0.036 IU/L | [107] |
CAP | CAP antibody modified-MNPs | 1.0 pg/mL | [108] |